Compare VCEL & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | KW |
|---|---|---|
| Founded | 1989 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1996 | 2007 |
| Metric | VCEL | KW |
|---|---|---|
| Price | $35.76 | $10.90 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $57.75 | $11.00 |
| AVG Volume (30 Days) | 557.8K | ★ 721.7K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.40% |
| EPS Growth | ★ 60.00 | 50.00 |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $276,259,000.00 | $62,633,000.00 |
| Revenue This Year | $19.40 | $81.79 |
| Revenue Next Year | $18.24 | N/A |
| P/E Ratio | $106.89 | ★ N/A |
| Revenue Growth | 16.45 | ★ 23.94 |
| 52 Week Low | $28.95 | $5.98 |
| 52 Week High | $45.97 | $10.99 |
| Indicator | VCEL | KW |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 56.19 |
| Support Level | $34.26 | $10.82 |
| Resistance Level | $38.48 | $10.99 |
| Average True Range (ATR) | 1.31 | 0.02 |
| MACD | 0.18 | -0.01 |
| Stochastic Oscillator | 94.02 | 70.00 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.